Adial Pharmaceuticals, Inc. (ADIL) vs Cellectar Biosciences, Inc. (CLRB)
A side-by-side comparison of Adial Pharmaceuticals, Inc. and Cellectar Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADIL
Adial Pharmaceuticals, Inc.
$4.35HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CLRB
Cellectar Biosciences, Inc.
$1.67HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ADIL vs CLRB
growth of $100 · dividends reinvested · last 8yADIL -99.8% (-54.9%/yr)CLRB -99.8% (-52.8%/yr)CLRB compounded faster over this window
ADIL CLRB
ADIL vs CLRB: by the numbers
- •CLRB is the larger company ($13M vs $11M market cap).
Metrics side by side
Valuation
| Metric | ADIL | CLRB |
|---|---|---|
| P/B ratio | N/A | 0.45 |
Profitability
| Metric | ADIL | CLRB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -37052.06% | -74.73% |
| ROIC | -240.64% | -74.94% |
Growth (annualized)
| Metric | ADIL | CLRB |
|---|---|---|
| Total return CAGR (5Y) | -71.86% | -60.51% |
Frequently asked
- How have ADIL and CLRB total returns compared?
- Over the past 5 years, ADIL delivered -71.86% and CLRB delivered -60.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.